Renaissance Technologies’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-337,600
Closed -$31.2M 3352
2026
Q1
$31.2M Sell
337,600
-264,700
-44% -$26.6M 0.05% 478
2025
Q4
$61.5M Buy
602,300
+70,453
+13% +$6.3M 0.1% 239
2025
Q3
$33.2M Sell
531,847
-143,353
-21% -$7.8M 0.04% 500
2025
Q2
$35.1M Buy
675,200
+58,700
+10% +$2.62M 0.05% 465
2025
Q1
$26.3M Buy
616,500
+113,400
+23% +$4.89M 0.04% 555
2024
Q4
$15.4M Buy
503,100
+64,700
+15% +$1.82M 0.02% 780
2024
Q3
$10.1M Buy
+438,400
New +$12.4M 0.02% 1033
2023
Q2
Sell
-213,400
Closed -$5M 4050
2023
Q1
$5M Buy
+213,400
New +$6.1M 0.01% 1474
2021
Q2
Sell
-87,500
Closed -$13.4M 3573
2021
Q1
$13.4M Sell
87,500
-42,000
-32% -$6.35M 0.02% 1013
2020
Q4
$16.7M Buy
+129,500
New +$14.9M 0.02% 847
2020
Q3
Sell
-128,300
Closed -$10.4M 3477
2020
Q2
$10.4M Buy
+128,300
New +$10.3M 0.01% 1196
2019
Q4
Sell
-320,600
Closed -$20.5M 3588
2019
Q3
$20.5M Buy
+320,600
New +$28.2M 0.02% 949

Other funds holding GH

Renaissance Technologies's GH Position: Q2 2026 in Review

Renaissance Technologies sold out of Guardant Health (GH) in Q2 2026, closing a stake of 337,600 shares — an estimated $31.2M sold.

Renaissance Technologies first reported a position in GH in Q3 2019 and held it in 12 quarters. The position peaked at $61.5M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Renaissance Technologies reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Renaissance Technologies sold 337,600 Guardant Health shares in Q2 2026, an estimated $31.2M.
  • Renaissance Technologies first reported a position in Guardant Health in Q3 2019 and held it in 12 quarters.
  • Renaissance Technologies's Guardant Health position peaked at $61.5M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.